In vitro induction of apoptosis and in vivo effects of a flavone nitroderivative in murine mammary adenocarcinoma cells

International Journal of Cancer

Volumn 125, Issue 1, 2009, Pages 222-228

  Cárdenas, Mariano G ^a   Zotta, Elsa ^a   Marder, Mariel ^a   Roguin, Leonor P ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

2 nitroflavone; Antitumor action; Apoptosis: Caspases; Murine mammary adenocarcinoma

Indexed keywords

2' NITROFLAVONE; CASPASE 3; CASPASE 8; CASPASE 9; CYTOCHROME C; FAS ANTIGEN; FLAVONE DERIVATIVE; FLAVONOID; PROTEIN BAX; UNCLASSIFIED DRUG; 2'-NITROFLAVONE; CASPASE; PROTEIN BCL 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST ADENOCARCINOMA; CELL DEATH; CELL POPULATION; CONTROLLED STUDY; CYTOSOL; CYTOTOXICITY; DIPLOIDY; DNA FRAGMENTATION; DRUG DOSE REDUCTION; ENZYME ACTIVATION; FEMALE; GROWTH INHIBITION; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NICK END LABELING; NONHUMAN; ORGAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; TUMOR CELL; TUMOR CELL DESTRUCTION; TUMOR GROWTH; TUMOR VOLUME; WESTERN BLOTTING; ADENOCARCINOMA; ANIMAL; BAGG ALBINO MOUSE; DRUG EFFECT; DRUG SCREENING; EXPERIMENTAL NEOPLASM; FLOW CYTOMETRY; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ADENOCARCINOMA; ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CASPASES; CELL LINE, TUMOR; CYTOCHROMES C; FEMALE; FLAVONES; FLOW CYTOMETRY; IN SITU NICK-END LABELING; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; PROTO-ONCOGENE PROTEINS C-BCL-2; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 66149107982     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.24361     Document Type: Article

References (37)

1. Harborne JB, ed. The flavonoids. Advances in research since 1986. London: Chapman and Hall, 1999;619-52.
2. Middleton E, Jr, Kandaswami C, Theoharides TC. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 2000;52:673-751.
3. Birt DF, Hendrich S, Wang W. Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacol Ther 2001;90:57-177.
4. Le Marchand L. Cancer preventive effects of flavonoids - a review. Biomed Pharmacother 2002;56:296-301.
5. Yang CS, Landau JM, Huang MT, Newmark HL. Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu Rev Nutr 2001;21:381-406.
6. Kandaswami C, Lee LT, Lee PP, Hwang JJ, Ke FC, Huang YT, Lee MT. The antitumor activities of flavonoids. In Vivo 2005;19:895-909.
7. Ramos S. Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention. J Nutr Biochem 2007;18:427-42.
8. Steinmetz KA, Potter JD. Vegetables, fruit, and cancer prevention: a review. J Am Diet Assoc 1996;96:1027-39.
9. Ren W, Qiao Z, Wang H, Zhu L, Zhang L. Flavonoids: promising anticancer agents. Med Res Rev 2003;23:519-34.
10. Kinghorn AD, Su BN, Jang DS, Chang LC, Lee D, Gu JQ, Carcache-Blanco E, Pawlus AD, Lee SK, Park EJ, Cuendet M, Gills JJ, et al. Natural inhibitors of carcinogenesis. Planta Med 2004;70:691-705.
11. Manthey JA, Grohmann K, Guthrie N. Biological properties of citrus flavonoids pertaining to cancer and inflammation. Curr Med Chem 2001;8:135-53.
12. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
13. Hengartner MO. The biochemistry of apoptosis. Nature 2000;407:770-76.
14. Kaufmann SH, Hengartner MO. Programmed cell death: alive and well in the new millennium. Trends Cell Biol 2001;11:526-34.
15. McDonnell TJ, Meyn RE, Robertson LE. Implications of apoptotic cell death regulation in cancer therapy. Semin Cancer Biol 1995;6:53-60.
16. Bold RJ, Termuhlen PM, McConkey DJ. Apoptosis, cancer and cancer therapy. Surg Oncol 1997;6:133-42.
17. Choi YJ, Kang JS, Park JH, Lee YJ, Choi JS, Kang YH. Polyphenolic flavonoids differ in their antiapoptotic efficacy in hydrogen peroxide-treated human vascular endothelial cells. J Nutr 2003;133:985-91.
18. Ramos S. Cancer chemoprevention and chemotherapy: dietary polyphenols and signalling pathways. Mol Nutr Food Res 2008;52:507-26.
19. Cárdenas M, Marder M, Blank VC, Roguin LP. Antitumor activity of some natural flavonoids and synthetic derivatives on various human and murine cancer cell lines. Bioorg Med Chem 2006;14:2966-71.
20. Cárdenas MG, Blank VC, Marder M, Roguin LP. 20-nitroflavone induces cell cycle arrest and apoptosis in human cervical carcinoma cells. Cancer Lett 2008;268:146-57.
21. Marder M, Zinczuk J, Colombo MI, Wasowski C, Viola H, Wolfman C, Medina JH, Ruveda EA, Paladini AC. Synthesis of halogenated/nitrated flavone derivatives and evaluation of their affinity for the central benzodiazepine receptor. Bioorg Med Chem Lett 1997;7:2003-08.
22. Marder M, Viola H, Bacigaluppo JA, Colombo MI, Wasowski C, Wolfman C, Medinab JH, Rúvedac EA, Paladini AC. Detection of benzodiazepine receptor ligands in small libraries of flavone derivatives synthesized by solution phase combinatorial chemistry. Biochem Biophys Res Commun 1998;249:481-85.
23. Ladeda V, Adam AP, Puricelli L, Bal de Kier Joffé E. Apoptotic cell death in mammary adenocarcinoma cells is prevented by soluble factors present in the target organ of metastasis. Breast Cancer Res Treat 2001;69:39-51.
24. Arends MJ, Morris RG, Wyllie AH. Apoptosis. The role of the endonuclease. Am J Pathol 1990;136:593-608.
25. Hengartner MO. The biochemistry of apoptosis. Nature 2000;407:770-76.
26. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998;281:1309-12.
27. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science 1998;281:1312-16.
28. Grutter MG. Caspases: key players in programmed cell death. Curr Opin Struct Biol 2000;10:649-55.
29. Kaufmann SH, Hengartner MO. Programmed cell death: alive and well in the new millennium. Trends Cell Biology 2001;11:526-34.
30. Danial NN, Korsmeyer SJ. Cell death: critical control points. Cell 2004;116:205-19.
31. Adams JM, Cory S. Life-or-death decisions by the Bcl-2 protein family. Trends Biochem Sci 2001;26:61-66.
32. Shao ZM,Wu J, Shen ZZ, Barsky SH. Genistein exertsmultiple suppressive effects on human breast carcinoma cells. Cancer Res 1998;58:4851-57.
33. Shukla S, Mishra A, Fu P, MacLennan GT, Resnick MI, Gupta S. Up-regulation of insulin-like growth factor binding protein-3 by apigenin leads to growth inhibition and apoptosis of 22Rv1 xenograft in athymic nude mice. FASEB J 2005;19:2042-44.
34. Miocinovic R, McCabe NP, Keck RW, Jankun J, Hampton JA, Selman SH. In vivo and in vitro effect of baicalein on human prostate cancer cells. Int J Oncol 2005;26:241-46.
35. Drees M, Dengler WA, Roth T, Labonte H, Mayo J, Malspeis L, Grever M, Sausville EA, Fiebig HH. Flavopiridol (L86-8275): selective antitumor activity in vitro and activity in vivo for prostate carcinoma cells. Clin Cancer Res 1997;3:273-79.
36. Chung TW, Moon SK, Chang YC, Ko JH, Lee YC, Cho G, Kim S-H, Kim J-G, Kim C-H. Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: complete regression of hepatoma growth and metastasis by dual mechanism. FASEB J. 2004;18:1670-81.
37. Zhang Q, Pi J, Woods CG, Jarabek AM, Clewell HJ, Andersen ME. Hormesis and adaptative cellular control systems. Dose Response 2008;6:196-208.